October 20, 2021

In Vitro Diagnostics Market will Touch US$ 85.23 Bn by 2027: Says Precedence Research

Spread the love

The latest report in In Vitro Diagnostics Market Size, Share with COVID-19 Impact and Forecast to 2027, The in vitro diagnostics (IVD) market size is expected to reach USD 85.23 billion by 2027, registering a CAGR of above 5% during the forecast period 2020 to 2027. The study provides an analysis of the global in vitro diagnostics (IVD) market for the period 2016-2027, wherein 2020 to 2027 is the forecast period and 2020 is considered as the base year.

The study includes drivers and restraints of the global in vitro diagnostics (IVD) market. The main goal of this research study is to offer a clear picture and a better understanding of the market to the manufacturers, traders, and the suppliers operational in it. The readers can gain a deep insight into this market from this piece of information that can enable them to convey and develop critical approaches for the further growth of their businesses.

Market Estimations:

Market Was Valued In 2019: US$ 65.4 Billion

Market Is Projected To Grow By 2027: US$ 85.23 Billion

Compound Annual Growth Rate (CAGR): 5 percent

In vitro diagnostics are medical devices that are diagnoses a medical condition using assays and reagents. Tests can be performed on tissue or blood taken from human body. IVD become essential tool in order to diagnose and identify diseases plus offers projection and forecasting treatment response in clinical practice. Various in vitro diagnostics techniques available at present include hematology, immunodiagnostics, molecular diagnostics and tissue diagnostics. In vitro diagnostic can also be utilized to check a person’s health condition and offer them preventive measures. These IVDs may include next generation tests which require scanning persons DNA to detect genomic variations. Increasing demand for self-tests and point-of-care is projected to accelerate the growth of IVD treatments. Point-of-care testing segment of IVD market is growing rapidly as healthcare systems increasing their reliance on these technologies for informed patient care decisions with easy-to-use tests that offer speed and accuracy.

Development in molecular diagnostics and growing adoption of precision medicine has extended in vitro diagnostics application areas in modern medicine. Additionally, diagnostics center invests enough amounts on Research and Development. For instance, in 2018, players such as Roche, Sysmex and bioMerieuxspent around USD 1.4 billion, USD 158 million and USD 326 million respectively on R&D activities.

Download the Sample Pages for More Understanding@ https://www.precedenceresearch.com/sample/1130

Report Highlights

  • Existence of research organizations that offer clinical research, consulting services, and laboratory testing to cater the swelling demand for rapid diagnosis and treatment plans is likely to fuel the IVD market.
  • The growth of the IVD market is attributed to increasing geriatric population and rapid prevalence of acute and chronic diseases.
  • The in vitro diagnostic may include next generation sequencing tests which diagnoses persons DNA to catch genomic variations.
  • Emerging economies are predicted to offer lucrative opportunities for key players in the IVD market.

Growth Factors

The in vitro diagnostics market is expected to grow at a CAGR of around 5% over the forecast period and the market growth is majorly driven by increasing geriatric population. United Nations forecasted there were around 962 million people with age beyond 60 years in 2017. Further, substantial growth in the prevalence of acute as well as chronic diseases, growing adoption of automatic means and automation in laboratories will drive the IVD market. Growth in the condition specific tests increases significance for IVD tests in developing countries such as India and China which in turn propel the opportunities for key players in the market. Major factors driving the growth are technological advancement as well as focus of key players on constant introduction of innovative products. In addition, availability of Medicaid and Medicare facilities owing to increasing demand for disease diagnosis using IVD is projected to fuel growth in the IVD market over the forecast period. However, rigorous government regulations and adverse reimbursement policy may hinder the IVD market growth. Nonetheless, developing economies offers lucrative growth opportunities for manufacturers involved in the in vitro diagnostics market.

Increasing global spending on healthcare owing to increasing geriatric population and growing adoption of treatments and continuous advancements in technology is expected to propel the in vitro diagnostics market growth in the near future. However, the growth in developed market is predicted to remain steady whereas Asia Pacific and other developing markets will lead the in vitro diagnostics market over the forecast period.

Regional Snapshot

North American led to in vitro diagnostics market in 2019, owing to supportive government regulations, leading healthcare infrastructure and advancements into in vitro diagnostics system. In addition, owing to increasing awareness regarding viral disease detection and development of in vitro diagnostics kits for hospital labs is expected to drive the market growth in North America. For example, Lexent Bio entered partnership with Illuminia, Inc. in order to develop an IVD in vitro diagnostic kit for product offering of next generation sequencing based cancer diagnostics. On the other hand, Asia Pacific is anticipated to witness highest CAGR during the estimated time. Huge target population and upgrading healthcare infrastructure boosts the growth of IVD market in the region.

Key Players & Strategies

The in vitro diagnostics market is intensively competitive with presence of a large number of emerging players. The key market players include Alere, Inc., Hoffmann-La Roche Ltd., Arkray, Beckman coulter and many others. Major players in the market are developing innovative products and planning strategic initiatives, like mergers, acquisitions and collaborations in order to acquire significant market share and extend their product range. For instance, in 2018, Roche Diagnostics dominated the industry and revenues were double that of its competitors in the same year. Abbott Diagnostics acquired Alere and firmly held the second position in revenue. This acquisition led Abbott as the leader in point of care testing across the globe.

The major key players in the in vitro diagnostics market include:

  • Alere, Inc.
  • Hoffmann-La Roche Ltd.
  • Arkray
  • Beckman Coulter
  • Becton Disckinson
  • Bio-Rad laboratories
  • A.
  • Danaher
  • Sysmex Corporation
  • Abbott Laboratories

Segments Covered in the Report

This research study comprises complete assessment of the market by means of far-reaching qualitative and quantitative perceptions, and predictions regarding the market. This report delivers classification of marketplace into impending and niche sectors. Further, this research study calculates market size and its development drift at global, regional, and country from 2016 to 2027. This report contains market breakdown and its revenue estimation by classifying it based on product, application, technology and region as follows:

By Product

  • Reagents
  • Instruments
  • Services

By Technology

  • Immunoassay
    • Instruments
    • Reagents
    • Services
  • Hematology
    • Instruments
    • Reagents
    • Services
  • Clinical Chemistry
    • Instruments
    • Reagents
    • Services
  • Molecular Diagnostics
    • Instruments
    • Reagents
    • Services
  • Coagulation
    • Instruments
    • Reagents
    • Services
  • Microbiology
    • Instruments
    • Reagents
    • Services
  • Others
    • Instruments
    • Reagents
    • Services

By Application

  • Diabetes
  • Cardiology
  • Nephrology
  • Infectious Disease
  • Oncology
  • Drug Testing
  • Autoimmune Diseases
  • Others

 By Regional

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
  • Middle East & Africa
  • Latin America

COVID-19 Impact:

The industrial report mentions the influence of the ongoing COVID-19 pandemic. The outbreak has caused disturbances in several industries and has hammered the logistics, resulting in delayed deliveries and cancellation of product demand. The in vitro diagnostics (IVD) report proficiently explains the resulting factors and concerns of manufacturers. Researchers have also well-explained how the producers and providers will tackle the ongoing epidemic and the key strategies to be adopted post-pandemic for turning their businesses back to normal.

Why should you invest in this report?

If you are aiming to enter the global in vitro diagnostics (IVD) market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for in vitro diagnostics (IVD) are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2020-2027 so that you can plan your strategies to enter this market accordingly.

Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.

Buy this Premium Research Report@ https://www.precedenceresearch.com/checkout/1130

About Us:

Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and among different ventures present globally.

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Web: https://www.precedenceresearch.com

Blog: https://precedenceresearchnews.wordpress.com

Flair Insight

Flair Insight covers consultation, syndicated market studies, and customized research reports. We share online news distribution to different portals.

View all posts by Flair Insight →

Leave a Reply

Your email address will not be published. Required fields are marked *